Geneprodx
GeneproDX is a precision medicine company specializing in thyroid cancer diagnostics through its innovative ThyroidPrint® test. Combining genomics and artificial intelligence, the company offers a decentralized molecular diagnostic platform via the Idylla™ system, enabling rapid (under 3 hours) and accurate analysis of indeterminate thyroid nodules. This technology helps avoid unnecessary surgeries, reducing healthcare costs and improving patient outcomes globally. With patented technology validated in multiple countries and a presence in over 8 countries, GeneproDX targets a $2 billion global market, aiming to expand into the US, Asia, and other regions. The company operates a SaaS and service model, partnering with hospitals and healthcare providers worldwide to deliver its diagnostic solutions.
Geneprodx
GeneproDX is a precision medicine company specializing in thyroid cancer diagnostics through its innovative ThyroidPrint® test. Combining genomics and artificial intelligence, the company offers a decentralized molecular diagnostic platform via the Idylla™ system, enabling rapid (under 3 hours) and accurate analysis of indeterminate thyroid nodules. This technology helps avoid unnecessary surgeries, reducing healthcare costs and improving patient outcomes globally. With patented technology validated in multiple countries and a presence in over 8 countries, GeneproDX targets a $2 billion global market, aiming to expand into the US, Asia, and other regions. The company operates a SaaS and service model, partnering with hospitals and healthcare providers worldwide to deliver its diagnostic solutions.